Allergan ( AGN) returned to profit in the second quarter, as the maker of Botox posted a 13% increase in revenue.

The Irvine, Calif.-based company had a profit of $91.8 million, or 69 cents a share, vs. a loss of $107.9 million, or 83 cents a share, a year ago. On an adjusted basis, EPS came in at 64 cents, up from 53 cents a share in the year-ago period. Analysts were expecting 62 cents a share, according to Thomson First Call.

Revenue rose to $506.2 million vs. $441.5 million a year ago. Sales of the antiwrinkle cream Botox rose almost 24% to $176.9 million.

For the third quarter, the company said it expects pharmaceutical sales of $470 million to $485 million.

The company also forecast adjusted EPS of 66 cents to 67 cents in the third quarter and $2.72 to $2.75 in all of 2004. The consensus estimates are for 68 cents and $2.73 a share, respectively.

Recently, shares were off 29 cents, or 0.4%, to $71.71, having traded as high as $73.18.

More from Stocks

Danica Patrick's Final Race at 2018 Indianapolis 500: What She Thinks About Cars

Danica Patrick's Final Race at 2018 Indianapolis 500: What She Thinks About Cars

Why The FANG Stocks' Dominance May Not Be So Bad For The Market

Why The FANG Stocks' Dominance May Not Be So Bad For The Market

At End of May, Investors Signalling They May Stay Away

At End of May, Investors Signalling They May Stay Away

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever